Patient-derived datasets of melanoma, hepatocellular carcinoma, non-small cell lung cancer, and their respective adjacent healthy tissue controls have been previously used to show cancer-specific MALAT1-upregulation [12, 52, 61–65]. This evidence concerns the gene MALAT1 and hepatocellular carcinoma.